SECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C.
20549

Form
10-QSB

Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange
Act of 1934

For
Quarter Ended:     November 30, 2006

Mammatech Corporation(Exact name of
registrant as specified in its charter)

|                                        |  |                      
|--------------------------------------- |  | ---------------------
|Florida                                 |  | 0-11050              
|(State or
      other jurisdiction      |  | (Commission File No.)
|of
      incorporation or organization) |  |                      

|                                                | 
|----------------------------------------------- | 
|
|930 N.W. 8th Avenue,
      Gainesville, Florida | 
|(Address
      of principal executive offices)  | 

(352)
375-0607(Registrant's telephone number, including area
code)

Indicate
by check mark whether the registrant (1) has filed all reports required to be
filed by section 13 or 15 (d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant was required
to file such reports), and (2) has been subject to such filing requirements for
the past ninety days. Yes [   X   ] No [  ]

Indicate
by a check mark whether the registrant is a shell company (as defined in Rule
12b-2 of the Exchange Act)Yes [   ] No [ X ]

Indicate
the number of shares outstanding of each of the issuer's classes of common
stock, as of the latest practicable date:

Number of shares outstanding on Nov. 30, 20065,123,700 shares
of which303,925 are treasury shares

TITLE
OF EACH CLASS

Common
stock $.0001 par value

Transitional Small Business Disclosure Format Yes [   ] No
[ X ]

---

Mammatech Corporation

INDEX

|                                                                                                           | 
|---------------------------------------------------------------------------------------------------------- | 
|PART I                                                                                                     | 
|FINANCIAL
      INFORMATION                                                                                | 
|Item 1.
      Financial Statements                                                                         | 
|Balance
      Sheets for November 30, 2006                                                                 | 
|Statements
      of Operations for Three Months Ended Nov. 30, 2006 and Nov. 30,
    2005                  | 
|Statement
      of Cash Flow for the Three Months Ended Nov. 30, 2006 and Nov. 30,
      2005              | 
|Notes to
      Financial Statements for the Quarter Ended Nov. 30, 2006                                    | 
|Item 2.
      Management's Discussion and Analysis of Financial Conditions and Results
      of Operations | 
|Item 3.
      Controls and Procedures                                                                      | 
|PART
      II OTHER INFORMATION                                                                            | 
|Item 6.
      Exhibits and Reports on Form 8-K                                                             | 
|SIGNATURES                                                                                                 | 
|EXHIBITS                                                                                                   | 

2



---

---

Mammatech
CorporationBalance SheetNovember 30, 2006 (Unaudited) ASSETS

|                                                 | 
|------------------------------------------------ | 
|Current assets:                                  | 
|Cash                                             | 
|Accounts receivable - trade                      | 
|Inventory                                        | 
|                                                 | 
|Total current assets                             | 
|                                                 | 
|Property and equipment, at cost, net             | 
|                                                 | 
|Available for sale securities                    | 
|Patents, trademarks and other intangibles, net   | 
|                                                 | 
|                                                 | 
|                                                 | 
|                                                 | 
|                                                 | 
|                                                 | 
|LIABILITIES AND STOCKHOLDERS' EQUITY             | 
|                                                 | 
|Current liabilities:                             | 
|Accounts payable and accrued expenses            | 
|Accounts payable and accrued salaries - officers | 
|                                                 | 
|Total current liabilities                        | 
|                                                 | 
|Stockholders' equity:                            | 
|Common stock, $.0001 par value,                  | 
|200,000,000 shares authorized, 5,427,625         | 
|shares issued and outstanding                    | 
|Additional paid-in capital                       | 
|Accumulated (deficit)                            | 
|                                                 | 
|                                                 | 
|Treasury stock, at cost, 310,425 shares          | 
|                                                 | 
|                                                 | 
|Other comprehensive income:                      | 
|Unrealized gain on marketable securities         | 
|                                                 | 
|                                                 | 
|                                                 | 
|                                                 | 
|                                                 | 

See
accompanying notes to financial statements.

3



---

---



Mammatech
CorporationStatements of Comprehensive OperationsThree Months Ended November 30,
(Unaudited)

|                                               | 2006 | 2005                  
|---------------------------------------------- | ---- | ----------------------
|Sales, net                                     |      | $           105,308   
|Cost of sales                                  |      | 27,668                
|                                               |      |                       
|Gross profit                                   |      | 77,640                
|                                               |      |                       
|                                               |      |                       
|Selling, general and administrative expenses   |      | 111,361               
|                                               |      |                       
|(Loss) from operations                         |      | (33,721               
|                                               |      |                       
|                                               |      |                       
|Other income and (expense):                    |      |                       
|Gain (loss) on sale of investment securities   |      | (4,228                
|Interest and dividend income                   |      | 4,388                 
|                                               |      | 160                   
|                                               |      |                       
|                                               |      |                       
|(Loss) before income taxes                     |      | (33,561               
|Provision for income taxes                     |      |                      
|                                               |      |                       
|Net (loss)                                     |      | $            (33,561  
|                                               |      |                       
|                                               |      |                       
|Basic and fully diluted earnings per share:    |      |                       
|Net income  (loss)                             |      | $                (0.01
|                                               |      |                       
|Weighted average shares outstanding            |      | 5,427,625             
|                                               |      |                       
|                                               |      |                       
|Net (loss)                                     |      | $            (33,561  
|Unrealized gain (loss) from investments net of |      |                       
|income taxes                                   |      | 23,354                
|                                               |      |                       
|Comprehensive (loss)                           |      | $            (10,207  
|                                               |      |                       
|                                               |      |                       
|                                               |      |                       
|                                               |      |                       

See
accompanying notes to financial statements.

4



---

---

Mammatech
CorporationStatements of Cash FlowsThree Months Ended November 30,(Unaudited)

|                                                        | 2006 | 2005          
|------------------------------------------------------- | ---- | --------------
|Cash flows from operating activities:                   |      |               
|Net cash provided by (used in) operating activities     |      | $       20,047
|                                                        |      |               
|                                                        |      |               
|Cash flows from investing activities:                   |      |               
|Purchase of available for sale securities               |      | (76,278       
|Proceeds from the sale of available for sale securities |      | 116,005       
|Acquisition of property and equipment                   |      |              
|                                                        |      |               
|Net cash provided by (used in) investing activities     |      | 39,727        
|                                                        |      |               
|                                                        |      |               
|Cash flows from financing activities:                   |      |               
|Net cash (used in) financing activities                 |      |              
|                                                        |      |               
|                                                        |      |               
|(Decrease) in cash and cash equivalents                 |      | 59,774        
|Cash and cash equivalents,                              |      |               
|beginning of period                                     |      | 23,707        
|                                                        |      |               
|Cash and cash equivalents,                              |      |               
|end of period                                           |      | $       83,481
|                                                        |      |               
|                                                        |      |               

See
accompanying notes to financial statements.

5



---

---

MAMMATECH
CORPORATION

NOTES
TO FINANCIAL STATEMENTS

NOVEMBER
30, 2006

(UNAUDITED)

(1) Basis Of
Presentation

The
accompanying unaudited financial statements have been prepared in accordance
with generally accepted accounting principles (GAAP) for interim financial
information and Item 310(b) of Regulation S-B. They do not include all of the
information and footnotes required by GAAP for complete financial statements. In
the opinion of management, all adjustments (consisting only of normal recurring
adjustments) considered necessary for a fair presentation have been included.

The
results of operations for the periods presented are not necessarily indicative
of the results to be expected for the full year. For further information, refer
to the financial statements of the Company as of August 31, 2006, and for the
two years then ended, including notes thereto included in the Companys
Form 10-KSB.

(2) Earnings
Per Share

The
Company calculates net income (loss) per share as required by Statement of
Financial Accounting Standards (SFAS) 128, Earnings per Share. Basic
earnings (loss) per share is calculated by dividing net income (loss) by the
weighted average number of common shares outstanding for the period. Diluted
earnings (loss) per share is calculated by dividing net income (loss) by the
weighted average number of common shares and dilutive common stock equivalents
outstanding. During periods when anti-dilutive commons stock equivalents are not
considered in the computation.

(3) Inventory

Inventory
is stated at the lower of cost, determined on a first in, first out basis, or
market value. Inventory consists principally of finished goods and packaging
materials.

(4)
Available For Sale Securities

Marketable
securities consist of the following at November 30, 2006:

Mutual
funds and equity securities with a fair market value of $457,480. The cost basis
of these securities is $413,201.

The
gross realized losses on sales of available-for-sale securities were $4,228
during the three months ended November 30, 2006. The unrealized holding gains on
available-for-sale securities included in accumulated other comprehensive income
as a component of stockholders equity increased by $23,354 during the
three months ended November 30, 2006, and totaled $44,279 at November 30, 2006.

During
the three months ended November 30, 2006, the Company increased its investment
in available for sale securities by $76,278 and realized net proceeds from the
sale of available for sale securities of $116,005.

6



---

---

MANAGEMENTS
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATION FOR MAMMATECH
CORPORATION

The
following discussion  should be read in conjunction with the accompanying financial
statements  and notes thereto included within this Quarterly Report on Form 10-QSB. In
addition to historical information, the information in this discussion  contains
forward-looking statements within the meaning of Section 27A of  the Securities Act of
1933, as amended, and Section 21E of the Securities  Exchange Act of 1934, as amended.
These forward-looking statements involve  risks and uncertainties, including statements
regarding the Companys  capital needs, business strategy and expectations. Any
statements  contained herein that are not statements of historical facts may be deemed
to be forward-looking statements. In some cases, you can identify  forward-looking
statements by terminology such as may, will, should,
expect, plan, Intend, anticipate, believe,
estimate, predict,  potential or continue, the
negative of such terms or other comparable  terminology. Actual events or results may
differ materially. In evaluating  these statements, you should consider various factors
described in this  Quarterly Report, including the risk factors accompanying this
Quarterly  Report, and, from time to time, in other reports the Company files with  the
Securities and Exchange Commission. These factors may cause the  Companys actual
results to differ materially from any forward-looking  statement. The Company disclaims
any obligation to publicly update these  statements, or disclose any difference between
its actual results and  those reflected in these statements. The information constitutes
forward-looking statements within the meaning of the Private Securities  Litigation
Reform Act of 1995.

OVERVIEW

Results for the
first quarter of Fiscal 2007 were mixed. Sales increased by 5.5% over the previous
quarter and by 28.3% compared to  the first quarter of 2005. Operating costs of $111,361
represent a 19.5% increase relative to the prior year quarter. The net loss of  $33,561
is 32.2% greater than the corresponding figure from a year ago.

During the
quarter, the Company trained and certified 6 MammaCare Specialists, 10 MammaCare Clinical
Breast Examiners and 34  MammaCare BSE Instructors. The BSE Instructors were trained and
certified by the company's German affiliate.

The Company is
pursuing its strategy of establishing additional training sites both in the United States
and abroad. The Company  concluded negotiations with Alexian Brothers Hospital Network in
Elk Grove Village, IL and a MammaCare Training Center was opened in  that location in
December. There can be no assurance, however, that significant revenues will result from
this operation.

The Company
continues to expend resources to complete development of its patented tactile computer
technology tentatively termed the  Palpation Assessment Device (PAD). The PAD is the
first computer-based system that teaches and evaluates manual breast examination  skills.
During the quarter, the Company received a Phase I SBIR grant from the National Cancer
Institute to complete development of  the PAD and evaluate its utility in an online
learning environment. Currently, the PAD continues to undergo testing as part of
Specialist training.

The Company has
no immediate liquidity problems. The Company continues to seek an affiliation with a
larger partner in the healthcare  industry.

7



---

---

Item 3.   
Controls and Procedures

As of
the end of the period covered by this report, the Corporations Chief Executive
Officer and Chief Financial Officer evaluated the effectiveness of the Corporations
disclosure controls and procedures. Based on the evaluation, the Corporations Chief
Executive Officer and Chief Financial Officer concluded that the Corporations
disclosure controls and procedures are effective as of the end of the period covered by
this report in that information required to be disclosed in reports filed under the
Securities Exchange Act of 1934, as amended, has been recorded, processed, summarized and
reported within the current fiscal quarter. There were no changes in the Corporations
internal control over financial reporting that occurred during the Corporations
most recent fiscal quarter that have materially affected, or are reasonably likely to
materially affect, the Corporations internal control over financial reporting.

PART II - OTHER
INFORMATION

Item 1.     Legal
Proceedings

None

Item 2.     Changes
in securities

None

Item  3.      Default
upon senior securities

None

8



---

---

Item  4.     Submissions
of matters to a vote of securities holders

None

Item  5.      Other
information

None

Item 6.      Exhibits
and Reports on Form 8-K

None

9



---

---

| | MAMMATECH CORPORATION
| | ---------------------

| | BY:     /s/     
      Henry S. PennypackerPresident, Chief Executive Officer and and Director
| | ----------------------------------------------------------------------------------------------

| | BY:     /s/
           Mary SellersTreasurer, Chief
      Financial Officer and Director
| | ----------------------------------------------------------------------------------------

10